# Petition for Writ of Certiorari — Ellis v. Cates

> Briefs, arguments, decisions, and more.

URL: https://www.frixlaw.com/law-library/documents/brief%3Amicro_IA40386417_0871%3A1

## Record

- **Collection:** Supreme Court brief
- **Document type:** Petition for Writ of Certiorari
- **Published:** January 1, 1951
- **Citation:** 342 U.S. 870

## Text

IN THE

Hupreme Court of the Gnited States

Ocroser Term, 1951.

No. 340

Jutivus Hyman & Company, a Corporation; Jutrus Hyman,
individually and as President and Director of Julius
Hyman & Company; Roserr Sizser, individually and
as Secretary and Director of Julius Hyman & Com-
pany; Cuagtes A. Beckwith, Danie, E. Bonnet;
Nicx D’Amore; Ase DanisH; Epwarp Despres; Henry
Dupiak; Ernest Frermeicy ; Rex E. Livov; Wim E.
McCavtzey; THomas McKenna; Roy J. Mituer; Steve
Pocstk; Howarp Rosensaum; Yust Tasima; James F.
Warre; Farrz Worr and Sron Zevin, Petitioners,

Vv.

Vetsico: Corporation, Respondent.

PETITION FOR WRIT OF CERTIORARI TO THE
SUPREME COURT OF THE UNITED STATES AND
BRIEF IN SUPPORT.

CLAUDE PEPPER,
Attorney for Petitioners.

Passs or Byron S. Apams, Wasurrcton, D.C

IN THE

Supreme Court of the Anited States

Octoser TrERM, 1951.

No.

Jutius Hyman & Company, a Corporation; Jutius Hyman,
individually and as President and Director of Julius
Hyman & Company; Roserr Sizser, individually and
as Secretary and Director of Julius Hyman & Com-
pany; Cuartes A. Beckwith, Danie, KE. Bonnett;
Nicx D’Amore; Ase DanisH; Epwarp Despres; HENry
Dupiak; Ernest Frerreicn ; Rex FE. Linvov; Wii EF.
McCautey; THomas McKenna; Roy J. Miniter; Steve
Pocstk; Howarp Rosensaum; Yugi Tagrmma; James F.
Waite; Frirz Wor and Simon Zevin, Petitioners,

V.

Veutsico, Corporation, Respondent.

PETITION FCR WRIT OF CERTIORARI TO THE
SUPREME COURT OF THE UNITED STATES AND
BRIEF IN SUPPORT.

To the Honorable Chief Justice of the United States and
to the Associate Justices of the Supreme Court of the
United States:

Your petitioners above named, Juttus Hyman & Co.,
ET AL., pray that a Writ of Certiorari issue to the Supreme
Court of the State of Colorado to review the judgment of

EE ee Rn IRI ee mM Ste Oe ree nee Ome ie

2

that Court filed as modified June 25, 1951, affirming and
modifying a decree of the District Court of Denver, Colo-
rado, awarding a decree against petitioners in a sum exceed-
ing one million dollars and granting an injunction against
petitioner’s use of certain formulas and processes for the
manufacture of an insecticide known as chlordane.

SUMMARY STATEMENT OF THE CASE.

The events culminating in this petition began with a joint
venture aptly characterized by the trial judge ix this case
as follows:

**One man had the brains and the other had the money,
and one furnished the brains and the other furnished
the money. The man who furnished the genius had no
capital, as I understand it, and that relationship con-
tinued and was built up from, you might say, an actual
capital outlay of $16,000 to a potential of over a million
dollar concern.”’ (R. 2, fol. 3361)

The man with the brains was Dr. Julius Hyman, a bril-
liant 29 year old chemist who in 1931 had two patent appli-
cations pending covering uses of certain polymers which he
had discovered in the residue from the refining of gasoline
from crude petroleum. The product covered by the appli-
cations for patents was a synthetic fast drying oil substan-
tially equivalent to linseed oil. (R. 2, fols. 798-805)

The man with the money was Joseph Regenstein, a cousin
of Hyman, whom Hyman approached with the proposal
that they develop the subjects of the Hyman patent applica-
tions. (R. 2, fol. 807 ) Regenstein agreed with Hyman to
enter upon the joint venture of developing the subjects of
the two applications. Regenstein, his lawyer and an asso-
ciate worked out the corporate structure Regenstein and
Hyman were to employ in the enterprise. (R. 2, fol. 1526,
1675) They organized a corporation, known first as
Varnoil Corporation and later as Velsico] Corporation,
with $20,000.00 capital stock, $16,000.00 of which was issued
for cash to two of Regenstein’s corporations, Transo Cor-

= )

poration and Arvey Corporation, and $4,000.00 to Hyman
in return for the assignment of his two patent applications
to the corporation. (R. 2, fols. 1518,1519) Hyman was not
entirely satisfied with his 20 percent of the company for
his two patent applications in view of the small capitaliza-
tion, but he accepted the arrangement. (R. 2, fol. 2339)

Regenstein became the President of the corporation and
was consulted in financial matters. (R. 2, fol. 1557) Hyman
became Executive Vice-president and Director of Research,
and was its actual operating head. (R. 2, fols. 1517, 1557)
The organization and operation of the business were con-
ducted somewhat informally, with few formal meetings of
stockholders or directors. (Ex. 13)

After a slow beginning the business progressed; in 1937
Velsicol completed a plant at Marshall, Illinois. In order
to meet operating deficits and finance the building of the
plant, Regenstein’s two corporations loaned substantial
sums to Velsicol. (R. 2, fols. 934-936) During these years
Hyman contributed many inventions to Velsicol. (R. 2,
fol. 2162) In the early forties the company began to earn
profits, and by 1943 it had erased its operating deficit. (R.
2, fols. 944, 2162, Exs. 22-25)

In 1943 Hyman invented a process for production of
vitamin K, a blood clotting vitamin. (R. 2, fol. 2159) By
this time he had assigned 37 of his inventions to Velsicol
without consideration and Velsicol was at iast in sound
financial condition. Hyman notified Regens‘ein that he
would not assign this or future inventions to Velsicol unless
he was compensated in some way. (R. 2, fols. 2162-65)
Regenstein insisted that Hyman continue to assign patents
and assured him that his greater participation in the com-
pany ‘‘would be worked out to his satisfaction.’”’ (R. 2,
fols. 1735, 1742) Hyman, in reliance upon this assurance
of Regenstein, assigned this patent application and others
in due course until 1945. (R. 2, fols. 2167, 2377)

In that year, Hyman invented an insecticide, now known
as chlordane, tests of which showed great promise. (R. 2,
fol. 964) Patent applications were duly filed for the inven-

a

tion in this country (R. 2, fol. 964); petitioners offered
proof of the filing of similar applications in England, Bel-
gium and several other foreign countries and of the publica-
tion of the invention in Belgium in April and May 1946 and
in England in January 1947. (R. 2, fols. 3007-15, R. 5, fols.
3573, 3580, Exs. 34-36) Hyman did not assign the patent
applications for this invention.

In 1946 he demanded of Regenstein, as a condition of

assigning this invention, an increased interest in the com-
pany. (R. 2, fols. 2206-8) Regenstein insisted that the
invention be assigned and represented that the increase in
interest would then be discussed and arranged. (R. 2, fols.
1568, 1705) In view of the 1943 incident Hyman refused to
rely on this representation. Both Regenstein and Hyman
consulted attorneys. (R. 2, fols. 1756, 2229-3, 2389) Hyman
was advised by counsel that he was justified in his conten-
tion that he was not obligated to assign these applications,
and continued his refusal. (R. 2, fol. 2389, 2390) On Sep-
tember 13, 1946, Regenstein formally demanded of Hyman
that he assign them or resign. (R.2, fol. 2225) Hyman re-
signed. Shortly thereafter the directors controlled by Reg-
enstein voted to initiate suit in Illinois against Hyman for
the assignment of these insecticide patent applications and
the corporation brought suit. (Ex. 13)

Early in December 1946 Regenstein brought about a re-
capitalization of Velsicol whereunder shareholders were |
privileged to buy 34 new shares for each share held. (R.

1, fols. 348-63, Ex. 13) Regenstein’s two corporations paid |
for their stock with their notes of the corporation which
then totaled $528,000.00, Hyman was unable to raise
$136,000.00 to exercise his warrants. The new stock was
issued at $10.00 per share rather than at a price equal to
the actual value of the outstanding shares, which was in
excess of $1000.00 per $10.00 par share (R. 2, fol. 1691), or
even at their book value, in excess of $150.00 per share.
(Ex. 28) The result of the recapitalization was that
Hyman’s equity in the company was reduced from 20 per-

a

cent to less than 1 percent, and the book value of his inter-
est was reduced from approximately $70,000.00 to less than
$7,000.00, and its actual value reduced in the same propor-
tion and in an even greater amount.

Of this transaction the trial court in this case said:

5

““* * * In other words, assuming he (Dr. Hyman) is
wrong, this thing of just one man turning over and
wiping him out by a twist of the wrist because he has
the money, because he has the credit, because he has
the control. After he comes at odds and ends with Dr.
Hyman, he turns the switch over night and Dr. Hyman
has one percent. His profits are based on that, whereas
before it was based on 20 percent.’’ (R. 2, fol. 3196)

* * * * * * * * *

‘““* * * it appeals to me that if they (these facts) are
true that Dr. Hyman is being wiped out. And, as a
Chancellor sitting in a Court of Equity, that does not
appeal tome. Assuming this corporation was indebted
to the extent that it was, it appears now that it has now
become a solvent, money-making concern; and that by
a twist of the finger, so to speak, what was a debt is
| being fostered into a money-making apparatus; instead
of giving 4% the money is being turned in to wiping
out Dr. Hyman’s interest, and take any profit that
he might earn to make that loan make money in excess
of the interest. It just does not appeal to me, gentle-
men.’’ (R. 2, fols. 3186, 3187)

Thus after having contributed 15 years of his life and
many valuable inventions to this highly successful venture
of which he was unquestionably the key figure, Hyman
emerged with only an insignificant stock interest greatly re-
duced even from the admittedly insufficient interest he had
theretofore owned, jobless and faced with the necessity of
defending a suit for the assignment of the chlordane pat-
ents.

In the late fall of 1946 Hyman located and leased a war
surplus plant in Denver, Colorado, organized Julius Hyman
& Co., and by March of 1947 was in production of chlordane.
(R. 2, fols. 1010-24)

6

On April 11, 1947, Regenstein had Velsicol file his suit in
the District Court of the City and County of Denver, Colo-
rado, against Hyman, his corporation and a number of
former Velsicol chemists and employees who had left to
join Hyman in Denver. The complaint alleged that chlor-
dane belonged to Velsicol ; that Hyman signed an agreement
dated January 31, 1931 ‘that any and all inventions, im-
provements, discoveries, formulas or processes relating to
oils, paints, varnishes or any of the ingredients or products
thereof or relating to the manufacture or production of
oils, paints, varnishes or any of the ingredients or prod-
ucts thereof, invented, discovered or learned by the under-
signed during the term of his employment by the company—
will U2 the sole and absolute property of the company— |
and the undersigned at all times, both during his employ-
ment and after the termination of his employment, will
keep all of the same secret from everyone except the com-
pany .. .’’; that the other individual defendants signed
certain secrecy agreements with Velsicol; that they and
Hyman were also bound by confidential relations not to
disclose their knowledge of chlordane; and that Julius
Hyman & Co. acquired the process by the disclosures of
Hyman and the other defendants in violation of their
secrecy agreements and with notice of such secrecy agree-
ments. The bill prayed for a decree awarding Velsicol all

the profits made by Hyman & Co. from the sale of chlor-
dane, damages, and an injunction against the defendants’
producing chlordane. (R. 1, fols. 1-82)

In his answer Hyman denied signing any agreement with |
Velsicol, admitted that Velsicol had shop rights authorizing
it to continue to manufacture chlordane but asserted that he

ES Ft ga et i 2 ° ail

— — PEE LIEN

7

The answer of Julius Hyman & Co. adopted the defenses
of Hyman’s answer. (R. 3, fols. 298-303) The other in-
dividual defendants, while admitting the signing of secrecy
agreements, in all other respects joined in the defenses
stated in Hyman’s answer. (R. 2, fols. 305-319)

The District Court granted the injunction, decreed that
Julius Hyman & Co. pay damages and account for all its
profits from chlordane to Velsicol, and granted other relief.
The accounting resulted in a judgment for $1,559,063.30
profits and $100,000.00 special damages for reducing the
price of chlordane. The Supreme Court of Colorado
affirmed the lower Court, modifying the accounting judg-
ment to a net sum of $1,238,789.10 profits and $100,000.00
damages.

The decree of the District Court was based on its finding
that Hyman ‘‘agreed to devote his time to said corporation
(Velsicol) as a chemist perfecting the ideas contained in
said patent applications (referring to the two petroleum
by-products applications assigned in 1931), and to devote
his time amd efforts to develop new uses for petroleum re-
fining by-products at a salary to be agreed upon from time
to time as the condition of the company might warrant, and
that all invertions and discoveries (pertaining to uses of
petroleum refining by-products) were to be kept secret and
assigned to the plaintiff corporation ‘(italics and material
in parenthesis ours); that the other individuals signed
agreements to keep secret the products of Velsicol; that
Hyman converted Velsicol’s property; that all the individ-
ual defendants breached their secrecy agreements ; and that
Julius Hyman & Co. was unlawfully appropriating Velsi-
col’s trade secrets to its own use. (R. 2, fols. 3373-94)

During the trial the Court sustained objection to petition-
ers’ offer of evidence of the British patent applications and
consequent publication of chlordane, making the process
a part of the public domain (R. 2, fol. 3183) ; subsequent to
the trial the Court denied petitioners’ motion, based on an
affidavit of the Belgian patent disclosures and others, to

dissolve the in
3570, 3643)

The Supreme Court of Colorado sustained these findings

of the trial court and made the additional finding, expressly
rejected by the trial court, that Hyman and the other in-
dividual defendants were bound by their confidential rela-
tions with Velsicol not to disclose chlordane. It affirmed
the rejection of their evidence of publication on the ground
that they were estopped to take advantage of the publica-
tion of the invention. (R. 6, p. 54)

Meanwhile, in the Velsicol suit against Hyman in Illinois,
for assignment of the chlordane application, the Supreme
Court of Illinois had entered a judgment, which has become
final, reversing the Appellate Court of Illinois, First Dis-
trict, and requiring Hyman to assign.

Meanwhile, also, Hyman had sued Velsicol and Regen-
stein and the other directors to set aside the recapitaliza-
tion on the ground of fraud. In that case the Appellate
Court of Illinois, First District, had entered a judgment,
which has become final, reversing the Superior Court of
Cook County, Tlinois, and dismissing Hyman’s complaint
on the ground that the recapitalization was justified by the
high ratio of debts to capital stock which had existed prior
thereto, and was not fraudulent as to Hyman because he
was offered an opportunity to purchase additional shares
pro rata.

Thus the Supreme Court of Colorado would write an end
to thé venture of Regenstein and Hyman with Regenstein
owning the very profitable property of the venture, includ-
ing forty of Hyman’s inventions; with Regenstein having
a judgment of over a million dollars against Hyman, his
company and associates; with Hyman’s new business for
developing his invention destroyed and Hyman enjoined
from the use of his own invention. In short Hyman will
have been ensnared in Regenstein’s corporate web and
financially devoured.

junction and find no damages. (R. 5, fols.

ae

9

JURISDICTION.

This Court has jurisdiction under 28 U. S. C. Section
1257, subsection (3), because the Colorado Supreme Court
refused to allow petitioners the right to present the evi-
dence which would have voided the agreement not to dis-
close a trade secret which the Court enforced in its decree,
thus violating the Sherman Act. (15 U. S. C. Section 1)
That is, the agreement the Court enforced, being in re-
straint of trade, was valid only if it involved a trade secret.
Yet the Court refused on the ground of estoppel to allow
petitioners to present evidence to show no trade secret ex-
isted because the same had been eliminated by publication.

Cases relied on to support jurisdiction on this ground in-
clude MacGregor v. Westinghouse Electric and Manufac-
turing Co., 329 U. S. 402 (1947) ; Sola Electric Co. v. Jeffer-
son Electric Co., 317 U. S. 173 (1942); Nutt v. Knut, 200
U.S. 13 (1906) ; Conmar Products Corp. v. Universal Slide
Fastener Co., 172 F. 2d 150 (C. A. 2d, 1949).

This Court has jurisdiction of this cause under the same
section for the further reason that petitioners claim under
the Fourteenth Amendment to and the commerce clause of
the Constitution of the United States (Article 1, Section 8,
clause 3) the right to manufacture and sell in interstate
commerce a product of petitioner Hyman’s own invention
of which right the judgment of the Supreme Court of Colo-
rado deprives them without any evidence that Hyman pre-
cluded himself from the exercise of that right by agree-
ment and without any basis in law for the Court’s holding
that under the facts of this case Hyman was precluded by
his relations with Velsicol from its exercise.

Cases relied on to support jurisdiction on this ground in-
clude United Gas Public Service Co. v. Texas, 303
U.S. 123 (1938) ; First National Bank of Hartford, Wis. v.
City of Hartford, 273 U. S. 548 (1927); Southern Pacific
Co. v. Schuyler, 227 U. S. 601 (1913); United States v.
Joint Traffic Ass’n., 171 U. S. 505 (1898) ; Butchers’ Union
Slaughter House & Livestock Landing Co. v. Crescent City

10

Livestock Landing & Slaughter House Co., 111 U. S. 746
(1884),

The judgment of the Supreme Court of the State of Colo-
rado was entered May 28, 1951, (R. 6, p. 19), and its order
denying petition for rehearing and modifying its opinion
was entered June 25, 1951. (R. 6, p. 18)

QUESTIONS PRESENTED.

1. Is the judgment of the Supreme Court of Colorado in
conflict with the anti-trust laws of the United States in
restraining competition in subject matter not covered, at
the time of the breach of any fiduciary or contractual obli-
gation, by a subsisting trade secret?

2. Was a rule of estoppel properly invoked to exclude
evidence of the non-existence of the secrets as a result of
public disclosure, in enforcing a contract in restraint of
trade whose validity as an exception to the anti-trust laws
is based upon the protection of trade secrets?

3. Does the judgment of the Supreme Court of Colorado
deprive petitioners of their constitutional right to engage
in interstate commerce in that it is based upon a finding,
that the secrecy agreement found to have been executed by
Hyman with respondent covered his invention, chlordane,
which is without evidence to support it?

4. Does the judgment of the Supreme Court of Colorado
deprive petitioners of their constitutional right to engage
in interstate commerce in that it is based upon a finding,
that petitioner Julius Hyman executed a secrecy agreement
with respondent covered his invention, chlordane, which is
against the weight of the evidence?

5. Does the judgment of the Supreme Court of Colorado
deprive petitioners of their constitutional right to engage
in interstate commerce in that it is based upon a finding,
that petitioner Julius Hyman was bound by his relations
with respondent not to disclose his invention, chlordane,
which was erroneous as a matter of law?

Sete ae eee CNA PRAEGER TR ILI RIESE AAG NIE WEP I fe TAM OR RIES RS ORR

23

tions ever getting into the public domain. No witness was
put on the stand. No question was asked. Nothing was
done except to offer the four documents. This does not
amount to an offer of proof. Wigmore on Evidence, 3rd
Ed., See. 17.

Defendants’ argument that the Colorado District Court
denied to them the right to present evidence to show
that plaintiff’s trade secrets were in the public domain
by reason of the alleged disclosures in foreign countries
is an attempt to build a federal question out of nothing.
A federal question resting on a false assumption is
clearly deviod of merit. Parker v. McLain, 237 U. S.
469, 473.

The Colorado courts considered all of the evidence that
was offered by the defendants on the issue of whether
plaintiff had trade secrets which equity would protect.
These courts decided that the formulas and processes
relating to chlordane were trade secrets belonging to
plaintiff, that plaintiff had done nothing to disclose these
trade secrets to the public, that the secrets of chlordane
were not in the public domain, and that Hyman and his
confederates wrongfully appropriated these secrets to
their use and gain in violation of their contractual and
fiduciary relations to plaintiff. These are clearly questions
of general law and not of federal law. (Bell Telephone
Company v. Pennsylvania Public Utility Commission,
309 U.S. 30, 32; Kerfoot v. Farmers, etc. Bank, 218 U.S.
281, 288; King v. West Virginia, 216 U.S. 92, 100; Mam-
moth Mining Co. v. Grand Central Mining Co. 213 US.
72, 77; Christman v. Miller, 197 U.S. 313, 319.) Where the
decision of a state court rests on adequate non-federal
grounds, this Court will not review the decision. (Herb
v. Pitcairn, 324 U.S. 117, 126; Southwestern Bell Tele-

24

phone Co. v. Oklahoma, 303 U.S. 206, 212; Fox Film Corp.
v. Muller, 296 U.S. 207, 210; Lynch v. New York, 293 US.
52, 54; Richardson Machine Co. v. Scott, 276 U.S. 128,
133; Enterprise Irrigation Dist. vy. Canal Co., 243 U.S.
157, 163-5; Bacon v. Texas, 163 U.S. 207, 216; California
Powder Works v. Davis, 151 U.S. 389, 393.) Where a state
court decision rests on an adequate non-federal ground
this Court is not concerned with the correctness of the
decision. Worcester County Trust Co. v. Riley, 302 U.S.
292, 299; Great Northern Ry. Co. v. Sunburst O. & R. Co.
287 U.S. 358, 365; Nickel v. Cole, 256 U.S. 222, 225;
Arkansas Southern R. Co. v. German National Bank,
207 U.S. 270, 275.

The second ground brought forward by petitioners (p.
9) to find some peg on which to hang the question of the
jurisdiction of this Court is even a greater sham. The
decree of the Superior Court of Cook County, Illinois,
(R. V, 10-12,) affirmed by the Supreme Court of Illinois,
(405 Ill. 352.) and which this Court refused to review,
(339 U.S. 966,) settles beyond dispute that ‘‘Hyman pre-
cluded himself from the exercise of that right [right to
make and sell chlordane] by agreement’’ and ‘‘that under
the facts of this case Hyman was precluded by his rela-
tions with Velsicol from its exercise.’’ These questions
cannot he relitigated.

In disposing of the contention that the District Court
erred in excluding the proffered exhibits, the Colorado
Supreme Court applied the familiar rule that one cannot
take advantage of his own wrong. It found that Hyman
had complete control of the filing and prosecution of the
foreign applications covering chlordane, (R. VI, 26,) that
if any disclosures of trade secrets resulted from the

co etnies ey hep "7 ‘ BEETS ee ENERO ROT TAG AERA SP a

25

operation of law in these foreign countries upon said
applications Hyman is directly responsible for such dis-
closures, (R. VI, 38,) and that the conduct of defendants
in betraying the confidence of plaintiff and in appropriat-
ing to their own use and benefit plaintiff’s trade secrets
is abhorrent to its conception of ordinary honesty. R. VI,
51-55.

Defendants advance the novel theory, rejected by the
Colorado courts and by every court that has ever con-
sidered the question, that an employee who learns his
employer’s trade secrets in confidence may insulate him-
self against a decree of injunction and accounting by
making a disclosure of his employer’s secrets before he
appropriates them to his use and profit. The mere state-
ment of the proposition is its own best answer.

It appears clear that this Court is without authority to
review the judgment of the Supreme Court of Colorado
and that the petition should be dismissed on that ground.

CASE CORRECTLY DECIDED.

We think we have shown that this case is one to be
determined by general principles of equity jurisprudence
and is unaffected by anything found in the Constitution,
treaties or statutes of the United States and that this
Court is without jurisdiction to review the decision of
the Colorado Supreme Court. But, if this case were be-
fore this Court on the merits, it has been correctly de-
cided and there is no purpose to be served by further
review. The decision of the Colorado Court is in full
accord with applicable decisions of this Court and of
other federal courts and of every state court that has
ever passed on a question of similar character. There

—_

26

is no case which supports the monstrous doctrine, ad-
vanced in the petition, that the public interest is served
by ‘‘dividing the wealth’? by the method eniployed by
Hyman and his confederates. Chlordane is the property
of Velsicol and defendants have no right to compete in
the production and sale of chlordane.

I,

The starting point in this case is not property, but
that the defendants stood in confidential relations to
plaintiff with respect to chlordane and its other secret
formulas, processes and products. Whether plaintiff has
been able to keep the secrets of chlordane and methods
of producing it from the public generally is not the issue
here. Defendants owe the plaintiff a duty with respect to
the formulas, processes and products here involved not
owed by the members of the public generally. The dis-
advantage of knowing plaintiff’s secrets is a burden de-
fendants cannot escape. [Equity will make certain that
defendants shall not fraudulently abuse the trust plain-
tiff reposed in them. (Dupont Powder Co, v. Masland,
244 U.S. 100, 102; Stone v. Goss, 65 N.J.. Eq. 756, 55
Atl. 736, 737-8; MacBeth-Evans Glass Co. v. Schnelbach,
239 Pa. 76, 86 Atl. 688, 693; Westervelt v. National Paper
& Supply Co., 154 Ind. 673, 57 N.E. 552, 544: Wireless
Speciality Apparatus Co. v. Mica Condenser Co., 239
Mass. 158, 131 N.E. 307, 310; Germo Mfg. Co. v. Combs,
209 Mo. App. 651, 240 S.W. 872, 881; Restatement of
Torts, See. 757, Vol. IV, pp. 5-10.) These cases dispose
of the first division of defendants’ argument. Pet. pp.
17-24.

The evidence shows beyond point of dispute that plain-
tiff diligently employed every reasonable means to keep

27

its secret formulas, processes and products out of the
public domain. No defendant denies this. In fact they
admit it. (R. Il, 195, 197, 201, 204, 431.) Whatever dis-
closures, if any, were made prior to September 13, 1946,
were made by or at the direction of Hyman as the opera-
ting head of plaintiff. He was the only person financially
interested in plaintiff who had any contact with plain-
tiff’s patent attorneys. (R. I], 351.) He filed the patent
applications relating to ‘‘Velsicol 1068’’ (chlordane) in
his own name as the inventor and he had complete con-
trol of these applications, domestic and foreign. (R. LI,
350.) Plaintiff did not and could not have taken any
action with respect to the pending patent applications re-
lating to chlordane prior to the time it procured the
assignment of these applications after the conclusion of
the Illinois case in late 1949. There is a complete ab-
sence of evidence that any stockholder, director or officer
of plaintiff other than Hyman, had any knowledge of the
filing of the applications relating to chlordane in any of
the foreign countries or that they had any knowledge
of the practice under the laws of these countries with
respect to laying applications open to public inspection.
If Hyman by his acts has lessened the protection to
which plaintiff is entitled from the general public, he
cannot take advantage of his own wrong and seek to
insulate himself against answering for his breach of
faith.

It is conceded that no defendant learned any of plain-
tiff’s secrets from the disclosures made by operation of
law in foreign countries or by any publication of the
United States Department of Agriculture, but they learned
what they know about chlordane and the methods of
producing it during and in the course of their employ-

—_—

oe ae ee

| eae area MONI Rt Al coh ei NE Seip ie ici Bh

28

ment with plaintiff. They had not only agreed in writing
to protect plaintiff in its secrets but the very nature of
their employment placed them under obligation to keep
in confidence what they learned in confidence. Whatever
defense would be available to one who independently dis-
covered the same secrets defendants discovered in plain-
tiff’s employ, such a defense is not open to the individual
defendants who, in breach of their contractual and fidu-
ciary relations, have appropriated plaintiff’s secrets to
their own use and benefit, nor to the corporate defendant
which is the creature and instrumentality of the individual
defendants. These defendants conspired and confederated
to unlawfully appropriate plaintiff’s trade secrets and
to unfairly compete with plaintiff and they cannot
escape the consequences of their wrong-doing.

It is little wonder that defendants anticipated plain-
tiff’s reliance on the several decisions in the litigation
between Shellmar Products Company and Allen-Qualley
Company and undertook to distinguish the case. (Pet.
p. 20). The reasoning of these opinions is sound, is in
harmony with settled law, and has never been challenged
in so far as it has any application to the problems at
bar. They completely dispose of defendants’ contentions
that the disclosures with respect to the foreign applica-
tions relating to chlordane, if there were any disclosures,
can in any wise affect the rights and privileges of plain-
tiff as against defendants. The District Court (31 F.
2d 293) awarded Allen-Qualley an injunction notwith-
standing it appeared that the confection wrapper made
under plaintiff’s secret process might infringe on another
covered by an outstanding patent belonging to a third
person, holding that the question involved was the valid-
ity in equity of the acts of defendant in receiving in con-
fidence a disclosure of plaintiff’s secrets and appro-

af

29

priating them to its own use. The Court of Appeals for
the Seventh Circuit affirmed this decree. (36 F. 2d 623.)
Thereafter defendant filed a bill of review in the District
Court to modify the decree of injunction on the ground
that the trade secrets of plaintiff had been disclosed to
the world through the issuance of United States, British
and Canadian patents covering the method and machine
involved, and the District Court dismissed this complaint
for want of equity. The Court of Appeals affirmed this
decree with an instructive opinion, (87 F. 2d 104,) and
this Court denied certiorari. (301 U.S. 695.) The facts
in that case presented a much stronger situation for the
defendant than is presented for the defendants in the
ease at bar, but the Court of Appeals held in line with
the settled law that whatever the opportunities open to
the public generally, the defendant, having violated its
trust, was barred in equity from using plaintiff’s pro-
cess. It would be difficult to find a case more nearly in
point on the facts and equities with the case at bar.

The contention that this decision of the Seventh Cir-
cuit is in conflict with the decisions of the Second Cir-
euit in Picard v. United Aircraft Corp. 128 F. 2d 632,
and in Conmar Products Corp. v. Universal Slide Fa3-
tener Co. 172 F. 2d 150, (Pet. p. 20,) has been answered
by this Court. It denied certiorari in the first of the two
eases, (317 U.S. 651,) and we must assume that if this
Court had considered that the decisions of the two Courts
of Appeal were in conflict on an important question of
law, it would have taken the Picard case and resolved
the conflict. The facts clearly distinguish the cases. In
the Conmar case the decision was for the defendant be-
cause it was held that he was not under duty under the
facts of that case not to disclose the secrets there in-
volved.

+A
eA
i Pi. : ees ROTARY RRR

30

Other decisions of federal courts in harmony with the
decision of the Colorado Supreme Court in this case
on the point that the owner of a trade secret is entitled
to protection in equity from its appropriation by one
who has learned the secret in confidence, whether the
secret is patentable or not, are Hoeltke v. C. M. K emp
Mfg. Co. (C.A. 4), 80 F. 2d 912, 922, cert. denied, 298 U.S.
673, and A. O. Smith Corp. v. Petroleum Iron Works Co.
(C.A. 6), 73 F. 2d 531, 537, 74 F. 2d 935.

Another case which holds squarely against the con-
tentions of defendants, and the effect of which they seek
to avoid by saying that the trade secrets there were dis-
closed by the employer to the employee rather than by
the employee to the employer, is Vulcan Detinning Co. v.
American Can Co. 72 N.J. Eq. 387, 67 Atl. 339. We sub-
mit that the new attorney for defendants has read the
opinion in this case carelessly. Vulcan brought suit
against American to restrain the latter from using a
secret process for separating tin from iron in tin scrap.
German scientists discovered the process and one Laernos
pirated it. Adolph Kern organized Vulean Metal Re-
fining Company and began using the stolen process in
this country. Vulean Detinning Company acquired Kern’s
company and the process which it kept secret. Franz
Assman, one of the original incorporators of Vulcan
Metal, had one of four copies of the process in his cus-
tody. Subsequently he sold his stock in Vulcan Detin-
ning and became associated with American (an as its
president. American instal'ed two plants using a process
of detinning similar to the process used by Vulean, hav-
ing employed for this purpose three former employees
of Vulean. These facts show clearly that Vulean, like
Velsicol, learned the trade secrets from an employee who,

Bein.

31

like Hyman, later undertook to appropriate them. Cer-
tainly Vulean did not communicate anything to its or-
ganizers who had obtained the secrets before Vulcan
was organized. In holding that Vulean was entitled to
an injunction to protect its process from use by those
who had control of its trade secrets by virtue of the con-
fidential relation, the Court said in part: (67 Atl. 343)

‘*Looking, now, a little more closely at the nature
of the relief called for by the complainant’s case
which we are now enabled to do in the light of the
issues that have been actually tried, we shall see,
I think, that too much emphasis has perhaps been
placed upon the element of absolute secrecy in the
process, and that not enough stress has been laid
upon the inequitable character of the defendants’
conduct in making a use of such process that was
inimical to the complainant’s interests. * * * IT am
now saying that the main ground for relief dis-
closed by the complainant’s case is the existence of
inequitable competition arising from a breach of
trust, and hence referable to general principles of
equity, and not to those special doctrines by which
unpatented secrets are protected. In the application
of these general principles the secrecy with which a
court of equity deals is not necessarily that absolute
secrecy that inheres in discovery, but that qualified
secrecy that arises from mutual understanding, and
that is required alike by good faith and by good
morals. * * *

*“*The conclusions to which the foregoing considera-
tions lead is that, entirely aside from the technical
secrecy of the process or the abstract question of
property therein, the complainant is entitled to have
its trustee, his associates, and their servants re-
strained from using against the interests of the com-
plainant the very process with which its trustee
was intrusted for its benefit.’

32

Schavoir vy. American Rebonded Leather Co. 104 Conn.
472, 133 Atl. 582, is another case where the plaintiff was
given protection in equity notwithstanding he made use
of elements in the manufacture of channel cloth which,
in certain combinations, were covered by an old patent
which he did not own, since a trade secret will be pro-
tected from wrongful disclosure though the owner of the
secret cannot secure property rights in it under the
patent law. In that case the defendant’s knowledge of the
process came to it in confidence, and its defense on the
ground that the secret was in the public domain was
denied, the Court saying: (133 Atl. 583)

“It is open to any one to use the same process,
provided they came by the necessary knowledge fair-
ly. * * * The knowledge of the process which the
defendant had was obtained by reason of the confi-
dence reposed in it by the plaintiff and upon its
express promise not to divulge the information so
secured and to use the formula only as authorized
by the plaintiff. * * * In such a situation, the right
of the plaintiff to protection in equity is amply
established.’’

It is well settled that the fundamental basis for relief
in a case of this character is a violation of trust and
confidence and that the case must be determined on gen-
eral principles of equity and not upon technical rules re-
lating to discovery and invention. DuPont Powder Co. v.
Masland, 244 U.S. 100, 102; Wireless Specialty Apparatus
Co. v. Mica Condenser Co. 239 Mass. 158, 131 N.E. 307,
310; Germo Mfg. Co. v. Combs, 209 Mo. App. 651, 240
S.W. 872, 882; State v. Neal, 152 Fla. 582, 12 So. 2d
590, 592; Meinhard v. Salomon, 249 N.Y. 458, 164 N.E.
545, 546; Nims on Unfair Competition, 4th Ed. Sees. 149-
151.

_— :
33

The cases cited by defendants (Pet. p. 19) to the effect
that ‘‘a restraint of trade cannot be based upon an
estoppel’’ have no relation to the facts in the case at
bar. MacGregor v. Westinghouse E. & M. Co. 329 US.
402; Edward Katzinger Co. v. Chicago Metallic Mfg. Co.,
329 U.S. 394, and Sola Electric Co. v. Jefferson Electric
Co. 317 U.S. 173, presented the question whether a li-
eensee by virtue of his license agreement is estopped to
challenge a price-fixing clause by showing that the patent
is invalid and that the price restriction is accordingly
unlawful because not protected by the patent monopoly,
and it was held that this defense was available to the
defendant. These cases came up through the federal courts
and in each case the Sherman Anti-Trust Act was spe-
cifically pleaded as a defense. In this case no title, right,
privilege or immunity asserted by the defendants grows
out of the Sherman Anti-Trust Act and in such situation
no federal question is presented. (Los Angeles, etc. Co.
v. Los Angeles, 217 U.S. 217, 228; Allen v. Arguimbau,
198 U.S. 149, 155; Alen v. Southern Pacific R. Co. 173
U.S. 479, 489; Miller v. Lancaster Bank, 106 U.S. 542,
544; Long v. Converse, 91 U.S. 105, 113; Hale v. Gaines,
22 How. 144, 160; Montgomery v. Hernandez, 12 Wheat.
129, 132.) It was never the purpose of the Sherman-
Anti-Trust Act to protect the possessor of stolen prop-
erty. Scott Paper Co. v. Marcalus Mfg. Co. 326 US.
249, presented the question whether the assignor of a
patent is estopped by virtue of his assignment to defend
a suit for infringement of the assigned patent on the
ground that the alleged infringing device is that of a
prior art expired patent, and of course it was held that
the defense was available. No such question is presented
by the record in this case.

; a

To hold, as defendants suggest this Court should do,
that an employee may invoke the anti-trust laws as a
defense to a violation of his fiduciary and contractual
obligations to his employer would open the door to fraud
and breach of trust. The obligation of an employee,
whether imposed by express contract or arising from the
relationship of the parties, not to appropriate to his
own use the trade secrets of his employer is clearly
not an agreement in restraint of trade. Competition is
unlawfully restrained only when competitors who have
a right to compete with each other are precluded from
so doing. Defendants, as the Colorado Supreme Court
has properly found, have no such right so far as chlor-
dane is concerned. It is the property of plaintiff. Defend-
ants have no rights in or title to it.

The argument that plaintiff has adopted the acts of
Hyman in filing the chlordane applications in foreign
countries (Pet. p. 21) does not change the fact that Hy-
man claimed to be the owner of the patent applications
relating to chlordane, that he filed the applications for
his benefit and not for the benefit of plaintiff, that he
had complete control of the filing and the prosecution
of the applications and that plaintiff got no control of
these applications until after it had won its suit in
Illinois to compel Hyman to assign these applications to
it. Plaintiff’s control came after the damage was done.

Neither reason nor authority supports the argument
of defendants (Pet. p. 22) that Hyman oecupies a shel-
tered position because he was the inventor of chlordane
and that he did not learn the secrets of chlordane from
plaintiff or any of its other employees. Pomeroy Ink
Co. v. Pomeroy, 77 N.J.Eq. 293, 78 Atl. 698, is squarely
in point against the argument. Eltweed Pomeroy was the

—_
35

president and general manager of Pomeroy Bros. Co. and
the trade secrets involved were largely the result of his
discoveries and experiments. Pomeroy Ink Co. purchased
the assets of Pomeroy Bros. Co., which included the trade
secrets. Eltweed Pomeroy became an employee of Pom-
eroy Ink Co. and was given charge of promoting the
sale of its products which were made by secret processes.
After he left the employ of the Company he offered
the secret formulas and processes to others, claiming
that he had the right to sell these formulas and processes
because he was the inventor. Disposing of this defense,
the Court said: (78 Atl. 699-700)

‘‘The present case is not one where complainant’s
right to the use of the formulas and formula notes,
as against the defendant, depends upon the principle
of ‘confidential communication, for, as to this feature of
the case, the defendant while an officer and manager
of the company was himself the inventor or dis-
coverer of the process, and communicated it to the
company. But the vital question in the case is whether
the defendant, the discoverer or inventor of the
processes disclosed by the formulas, transferred to
the Pomeroy Bros. Co. the exclusive right to the
formulas and formula notes as their property. If
so, such transfer is binding on him and passed with
the assets of the company to the complainant.’’

After analyzing the facts and finding that the complain-
ant, Pomeroy Ink Co., was the owner of the formulas
and processes, the Court applied the principle of the
eases which grant relief for breach of confidential com-
munication of trade secrets and held that Pomeroy should
be enjoined from disclosing the secrets and appropriating
them to his use and gain. Since it has already been finally
determined by the decree of the Illinois court that plain-
tiff is the owner of the chlordane secrets, it follows that

36

Hyman and his confederates have no right to use these
secrets in competition with plaintiff notwithstanding Hy-
man is the inventor.

Another case holding that the inventor should be en-
joined from carrying away the invention belonging in
equity to his employer and disclosing it to a competitor is
Wireless Specialty Apparatus Co. v. Mica Condenser Co.,
239 Mass. 158, 131 N.E. 307. Wireless had been engaged
in making radio condensers for the United States during
World War I and on the signing of the Armistice it
became apparent that the industry would be seriously
affected, if not ended, unless the company could produce
magneto condensers to be sold to manufactures of elecri-
cal apparatus. After extensive experiments plaintiff’s em-
ployees succeeded in bringing about the necessary changes.
McPherson, one of the employees, made application for
letters patent on the inventions and he assigned these
inventions to a competing company. The Court held that,
whatever the decision in a separate case to require the
assignment of the patent applications (the Illinois case
by plaintiff against Hyman, 405 Til. 352), plaintiff was
entitled to protection from misappropriation of the secrets
obtained by its employees in the course of their employ-
ment (the case at bar), saying: (131 N.E. 310)

“Although the first suit is decided on the basis
that the plaintiff is entitled to relief because it is the
equitable owner of the inventions already considered,
it does not follow that it can get nothing under the
second bill. It may be that no patent will issue be-
cause of lack of novelty or other reason and that the
plaintiff will in fact receive nothing of value under
any decree entered in the first suit. The fact that an
invention is patentable does not compel the taking
out of a patent, nor prevent the person entitled to it
from keeping it secret, nor bar him from equitable

—
37

relief against those disclosing its existence and de-
tails in violation of trust and confidence, nor as
against those who obtain knowledge through such
violation with notice and purpose to make use thereof.
The fundamental requirement for relief is a violation
of trust and confidence.’’

Conclusive against defendants’ position is the fact
that Hyman appropriated the secrets of ‘‘237’’, covered
by the Herzfeld-Lidov-Bluestone applications owned by
plaintiff, in making the compound covered by the chlor-
dane applications. Hyman knew nothing about the basic
compound ‘‘237’’, which is an essential ingredient of the
improved insecticide ‘‘1068’’, or chlordane, until ‘‘237’’
was discovered and developed in plaintiff’s laboratory by
plaintiff’s employees who were under contractual and
fiduciary obligations to plaintiff to assign the ‘237’
invention to plaintiff. Herzfeld, Lidov and Bluestone com-
plied with their duty to plaintiff and assigned the patent
applications relating to ‘‘237’’ simultaneously with the
execution of the applications. Hyman knew this and as
the executive head of Velsicol accepted the assignment
for Velsicol. Therefore the phony defense that he did not
learn the secrets of chlordane from those in confidential
relations to plaintiff blows up in his face. His contribu-
tion to the invention of chlordane was to suggest that
‘*237’’ be chlorinated. To his amazement, as well as
that of the other chemists employed by plaintiff, this
resulted in an entirely new composition of matter which
was an unusually effective insecticide and so he became
the inventor. To say that these circumstances of ihe
invention of chlordane by Hyman insulate him against
a suit for accounting for appropriation of the chlordane
secrets in wrongful competition with plaintiff is to intro-
duce a new conception of equity and honesty. The de-
cision in the Illinois case disposed of this defense and
held Hyman accountable.

II.

The questions presented under the second division of
petitioners’ argument (pp. 24-37 ) have all been conclu-
sively settled by final decisions of the Illinois courts. It
does not appear that the distinguished attorney, brought
into this case to prepare and present this petition, is
familiar with these earlier decisions.

Issues squarely presented in Velsicol Corporation v.
Julius Hyman, 405 Ill. 352, were the existence, interpreta-
tion, validity and enforceability of the agreement between
the parties, and the Court made a specific finding that
the agreement was executed and delivered as alleged in
the complaint, that it covered chlordane and the patent
applications relating thereto, and that it was valid and
enforceable in equity. The Supreme Court of Illinois
affirmed the decree compelling Hyman to assign the
chlordane applications and enjoining him and others in
privity with him from using the formulas, processes and
products covered by the applications and from disclosing
them to anyone other than plaintiff. This Court refused
to review the decision of the Supreme Court of Illinois.
339 U.S. 966.

Where the existence, validity and interpretation of a
contract has been adjudicated in one action it is con-
clusive hetween the same parties and their privies in
another action. Wilson’s Executor v. Deen, 121 U.S. 525,
532; Silurian Oil Co. v. Neal, 277 I. 45, 50; Albertson v.
Clark, 70 Colo. 129, 130; Freeman on Judgments, 5th
Ed. See. 894.

Even if the question of the validity, interpretation and
enforceability of Hyman’s agreement with Velsicol were
open for review, the decision of the Colorado court is

QE EE LOIS SE RIT EIA MGTIO it

PATA PLE ALI TG SOW ITS ASR MEN, TE

supported by the decisions of all federal and state courts
which have dealt with like questions. (New Jersey Zinc Co.
v. Singmaster, 4 F. Supp. 967, aff. 71 F. 2d 277, cert.
denied 293 U.S. 591; Paley v. DuPont Rayon Co. (C.A. 7)
71 F. 2d 856, 858; Hulse v. Bonsack Machine Co. (C.A. 4)
65 F. 864, 868; O. d W. Thum Co. v. Tloceynski, 114 Mich.
149, 72 N.W. 140, 144.) The individual defendants worked
under these agreements for the respective periods of their
employment and there was no difficulty in interpretation
while the parties were working in harmony. It was only
after defendants had violated the agreements and plain-
tiff was obliged to bring defendants to account that it
occurred to the defendants that the agreements were
unduly restrictive and were against public policy. The
rule is settled that a party cannot contend after a dispute
has arisen for construction of an agreement in violence
of the interpretation he has given the agreement in his
dealings with the other party during the period they
were working in harmony. Magnetic Mfg. Co. v. Dings
Magnetic Separator Co. (C.A. 7) 16 F. 2d 739, 741, cert.
denied, 274 U.S. 740; Street v. Chicago Wharfing Co.
157 Ill. 605, 614; Hinkle v. Blinn, 92 Colo. 302, 304.

The repeated assertion that Julius Hyman and Joseph
Regenstein were engaged in a joint venture and that
the corporate character of Velsicol Corporation should be
ignored has no support in the record. The fact is that
Hyman sought Regenstein’s assistance in the organization
of a corporation to establish and operate a research
laboratory to test, prove and develop some ideas which
Hyman had with respect to the use of petroleum refining
by-products and to carry on research and experimentation
generally in the field of chemistry. (R. II, 178-181, 261.)
Hyman had had extensive college training in chemistry

_— CueRee TUR Sart 16 Aa {RO BAW EEO Cotte NP SE II ia 2
—— CORBI LD OO LIT IOFIG ITE ALE PEALE EY LOE TONNE LEE ALAM, EAL ELOY. SIE
3 a ’ _

40

and some experience in research and Regenstein and his
business associates in Arvey end Transo relied on Hy-
man’s judgment as to the business possibilities. (R. II,
132-135, 267-274.) Plaintiff was regularly organized as a
corporation under the laws of Illinois and was regularly
conducted as such. Hyman became a director, officer, gen-
eral manager and director of research of plaintiff and
conducted its affairs as a corporation from the date of
its organization in January, 1931, to the date of his
resignation in September, 1946. He cannot now challenge
plaintiff’s corporate existence and pretend the under-
taking was a mere joint venture. (Kardo Co. v. Adams,
(C.A. 6), 231 F. 950, 967; Bushnell v. Consolidated I. &
M. Co., 138 Ill. 67, 74.) Furthermore, Hyman filed a suit
in the Superior Court of Cook County, Illinois, in De-
cember, 1946, setting up his rights as a stockholder in
Velsicol and sought to set aside certain recapitalization
proceedings. This was inconsistent with his claim that
he was a partner of Joseph Regenstein and not a stock-
holder in Velsicol Corporation. He lost this suit. Julius
Hyman v. Velsicol Corporation, 342 Ill. App. 489. Leave
to appeal was denied by the Supreme Court of Illinois.
343 Ill. App. ii.

The decrees in the Illinois eases could not have been
entered except that the Illinois courts found against
every contention made by the defendants under Division
II of their argument. Defendant Hyman made substan-
tially the same arguments in the Illinois cases that he
makes here and cited substantially the same authorities.
The decrees in these Illinois cases conclude all parties
and their privies as to matters essential to said decrees.
(Hart Steel Co, v. Railroad Supply Co., 244 U.S. 294, 298;
Elmhurst v. Kegerreis, 392 Ill. 195, 203; Clark vy. Knoz,

ORE PE TEs OA

41

32 Colo. 342, 348.) Under Section 1, Article IV of the
Constitution of the United States full faith and credit
must be given to these judicial proceedings in Illinois.
Magnolia Petroleum Co. v. Hunt, 320 U.S. 430, 438-9,

Conclusion.

The Supreme Court of Colorado has not decided a
federal question of substance nor has it decided a case
not in accord with applicable decisions of this Court.
The decision of that Court rests on adequate and inde-
pendent state grounds and under the decisions of this
Court there is no authority for further review.

Furthermore, the case is correctly decided and pre-
sents no new question which would justify this Court in
reviewing it if it had the authority.

Velsicol Corporation, respondent, prays that this pe-
tition be dismissed or denied for the reasons stated in
this answer.

Respectfully submitted,

FLoyp E. Tompson,
Ciype E. Sxorey,
Joun R. Coen,
Attorneys for Respondent.

Jounston, THompson, Raymonp & Mayer,
11 South LaSalle Street, Chicago 3, Illinois.

Suorey & Woops,
135 South LaSalle Street, Chicago 3, Illinois.

'
. “ o*~ ee a Sd
Pe LYON EP OTS gO ETT alin

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/documents/brief%3Amicro_IA40386417_0871%3A1. Public record. Not legal advice.
